Physician profile
Peter Farano
NPI 1194743989
$2,191.57
in general payments reported to CMS, 2019-2025
12 companies · $33.00 in 2025
The $33.00 reported for 2025 was less than what a typical Anatomic Pathology & Clinical Pathology provider received nationally (typical 2025 total: $50.59).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2021: $27.26 · 2022: $202 · 2023: $104 · 2024: $1,603 · 2025: $33.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,546 · Food and Beverage: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,545.80 |
| Food and Beverage | $194.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beckman Coulter, INC. | $1,583.13 | 2024 | Dxh 900 Hematology System |
| Siemens Medical Solutions USA, INC. | $235.08 | 2022-2025 | Atellica Ch 930 Analyzer, Atellica Im 1300 Analyzer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $104.07 | 2023 | |
| Celgene Corporation | $65.99 | 2019 | |
| Tesaro, INC. | $55.33 | 2019 | |
| Eisai INC. | $42.35 | 2019 | |
| Janssen Pharmaceuticals, INC | $27.26 | 2021 | |
| Cepheid | $19.32 | 2025 | Xpert Mrsa Nxg |
| American National Red Cross | $16.24 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.90 | 2019 | |
| Puma Biotechnology, INC. | $14.14 | 2019 | |
| Foundation Medicine, INC. | $12.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Farano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.